GlassScriptPhysician profile
Colette W Johnson
NPI 1154179190
$1,023.68
in general payments reported to CMS, 2019-2025
16 companies · $279 in 2025
The $279 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $745 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,024.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,023.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $189.23 | 2024-2025 | Jardiance, Mounjaro, Zepbound |
| Corcept Therapeutics | $134.78 | 2024 | Korlym |
| Dexcom, INC. | $95.59 | 2024-2025 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $92.26 | 2024-2025 | |
| Cequr Corporation | $72.84 | 2024 | Cequr Simplicity |
| Stryker Corporation | $57.59 | 2025 | Pangea |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.61 | 2024 | Jardiance |
| Amgen INC. | $55.63 | 2024 | Evenity, Prolia |
| Insulet Corporation | $50.86 | 2024 | Omnipod |
| Ascendis Pharma Endocrinology INC | $50.55 | 2025 | Yorvipath |
| Amphastar Pharmaceuticals, INC. | $44.58 | 2024-2025 | |
| Xeris Pharmaceuticals, INC. | $32.00 | 2024-2025 | Gvoke Hypopen |
| Intra-Sana Laboratories | $31.89 | 2024 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Averitas Pharma INC. | $27.29 | 2025 | Qutenza |
| Mannkind Corporation | $17.84 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $14.14 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colette Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.